![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/06/25/2903784/0/en/Kannalife-Secures-Funding-of-1-49-Million-from-The-Michael-J-Fox-Foundation-for-Parkinson-s-Research.html
https://www.globenewswire.com/news-release/2020/10/06/2104347/0/en/Kannalife-Inc-Adds-to-Its-Global-IP-Estate-Receiving-Patent-Grant-from-Canada-for-Its-Novel-Anti-Inflammatory-Compounds.html
https://www.globenewswire.com/news-release/2020/08/25/2083324/0/en/Kannalife-Inc-Receives-Patent-Grants-in-Additional-European-Territories.html#:~:text=The%20PCT%20Patent%20grants%20in,has%20received%20to%20date%20worldwide.&text=The%20two%20(2)%20U.S.%20patents,Treatment%20of%20Hepatic%20Encephalopathy%E2%80%9D%3B%20and
https://www.globenewswire.com/news-release/2020/06/30/2055494/0/en/Kannalife-Inc-Bolsters-IP-Portfolio-with-Multiple-Patents-Issued-in-12-Key-European-Territories.html